FDCP
OGN icon

Foster Dykema Cabot & Partners’s Organon & Co OGN Stock Holding History

Foster Dykema Cabot & Partners’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,711
Closed -$29K – 397
2025
Q3 		$29K Buy
+2,711
New +$26.6K ﹤0.01% 264

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
KBG
Kahn Brothers Group New York $633M AUM 39.01% 1-Year Est. Return

Foster Dykema Cabot & Partners's OGN Position: Q4 2025 in Review

Foster Dykema Cabot & Partners sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 2,711 shares — an estimated $29K sold.

Foster Dykema Cabot & Partners first reported a position in OGN in Q3 2025 and held it in 1 quarter. The position peaked at $29K in Q3 2025. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Foster Dykema Cabot & Partners reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • Foster Dykema Cabot & Partners sold 2,711 Organon & Co shares in Q4 2025, an estimated $29K.
  • Foster Dykema Cabot & Partners first reported a position in Organon & Co in Q3 2025 and held it in 1 quarter.
  • Foster Dykema Cabot & Partners's Organon & Co position peaked at $29K in Q3 2025.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Foster Dykema Cabot & Partners's 13F filing for Q4 2025, filed 12 Feb 2026.